Contact this trialFirst, we need to learn more about you.
CCR5 Antagonist
Maraviroc for Immune Reconstitution Inflammatory Syndrome
Recruiting2 awards10 criteria
Bethesda, Maryland
The purpose of this study is to determine if Maraviroc administration can decrease IRIS incidence in HIV infected patients initiating ARV therapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.